Overview
Updated 14 Jul 2026
Andrew Hendifar, MD, MPH, is Medical Director, Pancreatic Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center. The public record shows 462 publications with 14,236 citations (h-index 53), centered on Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Neuroendocrine Tumor Research Advances. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 22 companies.
- Most recent indexed publication: 2026 · Cancer epidemiology, biomarkers & prevention
- Top research focus: Pancreatic and Hepatic Oncology Research
- 14 registered trials on ClinicalTrials.gov
- Open Payments reporting from 22 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 140.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:
- Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)
Sponsor: Cedars-Sinai Medical Center
InvestigatorRecruitingNCT06988150 - Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer
Sponsor: Cantex Pharmaceuticals
InvestigatorPhase 1/PHASE2UnknownNCT05766748 - A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma
Sponsor: Andrew Hendifar, MD
InvestigatorEarly phase 1Active, not recruitingNCT05336266
Industry payments
Updated 14 Jul 2026
22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Exelixis Inc.Program year202517 payments$15,836openpaymentsdata.cms.gov ↗
- Ipsen Biopharmaceuticals, IncProgram year20258 payments$15,371openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20253 payments$11,275openpaymentsdata.cms.gov ↗
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 14 Jul 2026
182 congress contributions (2005–2025) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- Abstract 3182: Profiling of B7-H3 CAR T cells generated from patients with pancreatic ductal adenocarcinoma
AACR Annual Meeting
AACR2025Co-author - A supervised prehabilitation program for patients with pancreatic cancer.
ASCO Annual Meeting
ASCO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Circulating Tumor Cells as the Liquid Biopsy Foray into Noninvasive Colorectal Cancer Screening.
Cancer epidemiology, biomarkers & prevention
2026 - Evaluating the Effect of KRAS Variants on Survival Outcomes and Therapy Response in Pancreatic Cancer.
JCO precision oncology
2025
Most-cited worksby citation count (OpenAlex)
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
8733 Beverly Blvd, West Hollywood, CA 90048
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →everydayhealth.care ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →yelp.com ↗
- Board Certified: Hematology
Internal Medicine, and Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Residency
Los Angeles County + USC Medical Center; Hematology/Oncology Fellowship, University of Southern California (served as Chief Fellow)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uclaoliveview.org ↗
Editorial & leadership rolesjournal and society appointments
- Medical Director
Pancreatic Cancer Program, Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancernetwork.com ↗ - Lead
Gastrointestinal Disease Research Group, Cedars-Sinai
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗ - Director
Hematology/Oncology Fellowship Program, Cedars-Sinai
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchers.cedars-sinai.edu ↗
Awards & honorshonors on the public record
- Dr. Cynthia Mathis Physician Recognition Award (2025)
presented by BLOOM (Black Leaders Overtly Officiating Movement)
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pancan.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Secondary affiliationsappointments beyond the home institution
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
- Director
Hematology and Oncology Fellowship Program, Cedars-Sinai
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchers.cedars-sinai.edu ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- Text Q&A interview
CancerNetwork, on RAF-altered pancreatic cancer targeted therapy outcomes
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancernetwork.com ↗ - Guest
"Oncology Brothers" video podcast, episode on pancreatic cancer treatment algorithm (with Shubham Pant)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/andrew-hendifar-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Andrew-Hendifar
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/drhendifar
Mentions by otherswhere others cite or feature them
- Instagram
instagram.com/reel/DOW_iZkkZ03
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - LinkedIn
LinkedIn profile: Physician at Cedars Sinai Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Matthew Budoff, MD
Cedars-Sinai Medical Center
- 2,870
- publications
- 162
- h-index
- 13
- trials
Stephen Freedland, MD
Cedars-Sinai Medical Center
- 1,629
- publications
- 99
- h-index
- 6
- trials
Brennan Spiegel, MD
Cedars-Sinai Medical Center
- 643
- publications
- 81
- h-index
- 12
- trials
Michele Tagliati, MD
Cedars-Sinai Medical Center
- 192
- publications
- 54
- h-index
- 4
- trials